These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37389466)

  • 1. Curcumin Alleviates High-fat Diet-induced Nonalcoholic Steatohepatitis via Improving Hepatic Endothelial Function with Microbial Biotransformation in Rats.
    Wu J; Li M; Huang N; Guan F; Luo H; Chen L; Wei G; Li M; Lin Z; Su Z; Chen J; Liu Y
    J Agric Food Chem; 2023 Jul; 71(27):10338-10348. PubMed ID: 37389466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinate-curcumin improves NASH by inhibiting the AKR1B10/ACCα-mediated triglyceride synthesis.
    Lin XL; Zeng YL; Ning J; Cao Z; Bu LL; Liao WJ; Zhang ZM; Zhao TJ; Fu RG; Yang XF; Gong YZ; Lin LM; Cao DL; Zhang CP; Liao DF; Li YM; Zeng JG
    Lipids Health Dis; 2024 Jun; 23(1):201. PubMed ID: 38937844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K/AKT/mTOR and HIF-1/VEGF cascade.
    He Y; Wang H; Lin S; Chen T; Chang D; Sun Y; Wang C; Liu Y; Lu Y; Song J; Li S; Xu W; Lin Y; Zheng Y; Zhou X; Huang Q; Huang M
    Biomed Pharmacother; 2023 Sep; 165():115279. PubMed ID: 37544281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin analog CUR5-8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity.
    Lee ES; Kwon MH; Kim HM; Woo HB; Ahn CM; Chung CH
    Metabolism; 2020 Feb; 103():154015. PubMed ID: 31758951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin alleviates hepatic steatosis by improving mitochondrial function in postnatal overfed rats and fatty L02 cells through the SIRT3 pathway.
    Du S; Zhu X; Zhou N; Zheng W; Zhou W; Li X
    Food Funct; 2022 Feb; 13(4):2155-2171. PubMed ID: 35113098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation by Tetrahydrocurcumin of Adiposity and Hepatic Steatosis in Mice with High-Fat-Diet-Induced Obesity.
    Pan MH; Chen JW; Kong ZL; Wu JC; Ho CT; Lai CS
    J Agric Food Chem; 2018 Dec; 66(48):12685-12695. PubMed ID: 30415544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of
    Lee DE; Lee SJ; Kim SJ; Lee HS; Kwon OS
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31717261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
    Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
    Elife; 2023 Jan; 12():. PubMed ID: 36648330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
    Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
    Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages.
    Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K
    Biomed Pharmacother; 2020 May; 125():109895. PubMed ID: 32000066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    Bae CR; Zhang H; Kwon YG
    PLoS One; 2020; 15(12):e0243497. PubMed ID: 33275637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis.
    Nielsen MH; Gillum MP; Vrang N; Jelsing J; Hansen HH; Feigh M; Oró D
    Am J Physiol Gastrointest Liver Physiol; 2023 May; 324(5):G378-G388. PubMed ID: 36852934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.
    Honda T; Ishigami M; Luo F; Lingyun M; Ishizu Y; Kuzuya T; Hayashi K; Nakano I; Ishikawa T; Feng GG; Katano Y; Kohama T; Kitaura Y; Shimomura Y; Goto H; Hirooka Y
    Metabolism; 2017 Apr; 69():177-187. PubMed ID: 28285648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-loaded nanocomplexes ameliorate the severity of nonalcoholic steatohepatitis in hamsters infected with Opisthorchis viverrini.
    Sitthirach C; Charoensuk L; Pairojkul C; Chaidee A; Intuyod K; Pongking T; Thongpon P; Jantawong C; Hongsrichan N; Waraasawapati S; Yingklang M; Pinlaor S
    PLoS One; 2022; 17(9):e0275273. PubMed ID: 36166461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoprotective effect of curcumin against bisphenol A-induced hepatic steatosis via modulating gut microbiota dysbiosis and related gut-liver axis activation in CD-1 mice.
    Hong T; Jiang X; Zou J; Yang J; Zhang H; Mai H; Ling W; Feng D
    J Nutr Biochem; 2022 Nov; 109():109103. PubMed ID: 35780999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rk3 Regulates Nonalcoholic Steatohepatitis by Modulation of Intestinal Flora and the PI3K/AKT Signaling Pathway in C57BL/6 Mice.
    Guo M; Zhu C; Fu R; Ma X; Duan Z; Fan D
    J Agric Food Chem; 2023 Jun; 71(24):9370-9380. PubMed ID: 37288986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin preconditioned mesenchymal stem cells derived exosomes transplantation ameliorate and protect against non- alcoholic steatohepatitis by regulation the expression of key genes of inflammation and oxidative stress.
    Tawfeek GA; Kasem HA
    Transpl Immunol; 2023 Jun; 78():101837. PubMed ID: 37031771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vildagliptin alleviates liver fibrosis in NASH diabetic rats via modulation of insulin resistance, oxidative stress, and inflammatory cascades.
    Hendawy AS; El-Lakkany NM; Mantawy EM; Hammam OA; Botros SS; El-Demerdash E
    Life Sci; 2022 Sep; 304():120695. PubMed ID: 35671811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis.
    Hammoutene A; Biquard L; Lasselin J; Kheloufi M; Tanguy M; Vion AC; Mérian J; Colnot N; Loyer X; Tedgui A; Codogno P; Lotersztajn S; Paradis V; Boulanger CM; Rautou PE
    J Hepatol; 2020 Mar; 72(3):528-538. PubMed ID: 31726115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.